Myriad Genetics, Inc. (MYGN)
4.31
+0.11
(+2.62%)
USD |
NASDAQ |
Oct 09, 16:00
4.315
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Free Cash Flow (Quarterly) : -11.50M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.50M |
| March 31, 2026 | -22.20M |
| December 31, 2025 | 4.60M |
| September 30, 2025 | 14.90M |
| June 30, 2025 | -20.50M |
| March 31, 2025 | -24.60M |
| December 31, 2024 | 0.70M |
| September 30, 2024 | -5.60M |
| June 30, 2024 | -6.30M |
| March 31, 2024 | -27.20M |
| December 31, 2023 | -68.20M |
| September 30, 2023 | -39.60M |
| June 30, 2023 | -19.70M |
| March 31, 2023 | -56.70M |
| December 31, 2022 | -22.30M |
| September 30, 2022 | -20.20M |
| June 30, 2022 | -57.00M |
| March 31, 2022 | -52.80M |
| December 31, 2021 | -13.30M |
| September 30, 2021 | -42.30M |
| June 30, 2021 | -8.90M |
| March 31, 2021 | 63.50M |
| June 30, 2020 | 26.60M |
| March 31, 2020 | 13.80M |
| December 31, 2019 | -5.30M |
| Date | Value |
|---|---|
| September 30, 2019 | 14.40M |
| June 30, 2019 | 30.10M |
| March 31, 2019 | 3.50M |
| December 31, 2018 | 35.00M |
| September 30, 2018 | 6.50M |
| June 30, 2018 | 46.10M |
| March 31, 2018 | 8.60M |
| December 31, 2017 | 30.90M |
| September 30, 2017 | 21.90M |
| June 30, 2017 | 35.90M |
| March 31, 2017 | 39.60M |
| December 31, 2016 | 29.00M |
| September 30, 2016 | -4.40M |
| June 30, 2016 | 36.30M |
| March 31, 2016 | 61.30M |
| December 31, 2015 | 39.80M |
| September 30, 2015 | 23.90M |
| June 30, 2015 | 49.05M |
| March 31, 2015 | 25.42M |
| December 31, 2014 | 46.65M |
| September 30, 2014 | -4.521M |
| June 30, 2014 | 36.32M |
| March 31, 2014 | 9.694M |
| December 31, 2013 | 44.72M |
| September 30, 2013 | 85.22M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Natera, Inc. | -8.636M |
| Sera Prognostics, Inc. | -6.363M |
| BioRestorative Therapies, Inc. | -3.808M |
| CareDx, Inc. | 28.75M |
| Exagen, Inc. | 3.445M |